Nav: Home

Gains in access to antiretroviral treatment come with some costs

April 27, 2009

In this week's PLoS Medicine magazine, Yibeltal Assefa, from the National HIV/AIDS Prevention and Control Office in Addis Ababa, and colleagues describe the successes and challenges of the scale-up of antiretroviral treatment (ART) across Ethiopia. They report remarkable achievements in expansion of access to ART and to HIV counseling and testing (HCT), while managing to maintain the performance of other health programs such as tuberculosis and maternal and child health services. Task shifting to the health officers and health extension workers is thought to be responsible for these successes, say the authors.

At the same time, however, HIV prevention interventions and the management of chronic care patients are lagging behind now in Ethiopia. The authors say this may be due to lack of attention to these health care areas and to physicians leaving the public sector for non-governmental organizations (NGOs), including AIDS-related NGOs. They say urgent attention is needed in the areas of HIV prevention, management of chronic care patients, and retention of doctors in the public sector to ensure an effective and sustainable health system in Ethiopia.
Funding: No specific funding supported the production of this article.

Citation: Assefa Y, Jerene D, Lulseged S, Ooms G, Van Damme W (2009) Rapid Scale-Up of Antiretroviral Treatment in Ethiopia: Successes and System-Wide Effects. PLoS Med 6(4): e1000056. doi:10.1371/journal.pmed.1000056



Yibeltal Assefa
National HIV/AIDS Prevention and Control Office
Health Programs
African Avenue, Dembel City Centre
Addis Ababa 00251
+ 251911254246


Related Hiv Prevention Articles:

Researchers propose a new way to assess medication-based HIV prevention
Delivering on the promise of preventing HIV infections with antiretroviral medicines, or pre-exposure prophylaxis (PrEP), requires thinking about PrEP as a nine-step continuum of preventive care, Brown researchers write in the journal AIDS.
Reversing the HIV epidemic: Europe needs to scale-up prevention, testing and treatment
Maltese Presidency of the Council of the European Union Conference and the European Centre for Disease Prevention and Control (ECDC), HIV experts from across the European Union discuss how to reverse the HIV epidemic and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Opportunities for addiction care and HIV prevention in Russia
Researchers from Boston Medical Center (BMC), in collaboration with Brandeis University and Washington State University, conducted a study to estimate costs and reduction in disease burden if this treatment were available in Russia and implemented into their health care system.
CDC guidelines for HIV prevention regimen may not go far enough, study suggests
Study suggests that CDC guidelines for who should be on Preexposure prophylaxis (PrEP) don't go far enough because current standards could miss some people who should be on it.
HIV prevention trials network launches HPTN 083
The HIV Prevention Trials Network (HPTN) has launched a new study, HPTN 083, to evaluate whether injectable cabotegravir (CAB) can safely protect men who have sex with men (MSM) and transgender women (TGW) who have sex with men from acquiring HIV as well as daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC).
An integrated approach to HIV prevention
The Medical University of South Carolina has received a $3.1 million grant from the National Institutes of Health to study an integrated approach of screening and treatment for HIV, diabetes, and hypertension in Tanzania.
Study suggests additional benefits to HIV-prevention therapy
A new study suggests just how cost-effective this intervention -- known as pre-exposure prophylaxis, or PrEP -- could be in Toronto, and says there maybe additional benefits to a PrEP program if it brings high-risk individuals into contact with the health-care system and engages them in care.
Remote-controlled implantable device delivers HIV prevention drug
A Houston Methodist research team received a nearly $4 million grant to test a transcutaneously refillable implant that administers pre-exposure prophylaxis drugs to subjects at risk of HIV-exposure.
2016 recommendations for antiretroviral drugs for the treatment and prevention of HIV infection
In a report appearing in the July 12 issue of JAMA, an HIV/AIDS theme issue, Huldrych F.

Related Hiv Prevention Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...